Glenmark Ranitidine Tablets USP 300 mg Rx Only 30 Tablets Manufactured by: Glenmark Pharmaceuticals Ltd. Colvale-Bandez, Goa 403513, India Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ NDC 68462-249-30
Published January 15, 2020 · Recall initiated: December 17, 2019
Summary
FDA records drug Class II recall D-0641-2020, published January 15, 2020 and initiated December 17, 2019. Recalling firm: Glenmark Pharmaceuticals Inc., USA; Status: Ongoing; Reported quantity: 98,988 bottles; Lot: 7701429A 7701522A 7702255A 7704745A 19190456 19190472 19190490. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
CGMP Deviations: Presence of NDMA impurity detected in product.
What to do
Voluntary: Firm initiated · Press Release
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Glenmark Pharmaceuticals Inc., USA
- Distributor
- Natiowide
- Lot
- 7701429A 7701522A 7702255A 7704745A 19190456 19190472 19190490
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAAbiraterone Acetate Tablets USP 500 mg, 60-count bottles, Rx only, Distributed by: Glenmark PharmaceuticalsNovember 4, 2026
- FDAAzelaic Acid Gel, 15%, 50 gram tubes, For Topical Use only, Rx only, Distributed by: Glenmark PharmaceuticalsAugust 5, 2026
- FDAAlyacen 7/7/7, Norethindrone and Ethinyl Estradiol Tablets USP, 0.5mg/0.035mg, 0.75mg/0.035mg, 1 mg/0.0.35mg,June 24, 2026
- FDAOndansetron Orally Disintegrating Tablets, USP, 4mg, 30 Tablets (3 blistercards each containing 10 tablets),January 7, 2026
- FDAGlenmark Ranitidine Tablets USP 150 mg Rx Only 100 Tablets Manufactured by: Glenmark Pharmaceuticals Ltd.January 15, 2020
- FDAGlenmark Ranitidine Tablets USP 300 mg Rx Only 100 Tablets Manufactured by: Glenmark Pharmaceuticals Ltd.January 15, 2020
Questions about this recall
Was Glenmark Ranitidine Tablets USP 300 mg Rx Only 30 Tablets Manufactured by: Glenmark Pharmaceuticals Ltd. Colvale-Bandez, Goa 403513, India Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ NDC 68462-249-30 recalled?
Yes. FDA published recall D-0641-2020 on January 15, 2020. Reported hazard: CGMP Deviations: Presence of NDMA impurity detected in product.
What should I do if I have this product?
Voluntary: Firm initiated · Press Release